The Oncology Institute to Participate in the 25th Annual Needham Healthcare Conference
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI) announced that CEO Dr. Daniel Virnich and CFO Rob Carter will participate in the 25th Annual Needham Healthcare Conference on Wednesday, April 15, 2026, including a fireside chat at 3:45 p.m. ET.
A live webcast of the presentation will be accessible via the company's Investor Relations website.
Positive
- None.
Negative
- None.
News Market Reaction – TOI
In the Apr 9 session, TOI gained 0.32%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 06 | Executive appointment | Positive | +2.9% | Named a new Chief Legal Officer to oversee legal and compliance functions. |
| Mar 12 | Earnings and guidance | Positive | +8.4% | Reported strong 2025 revenue growth and issued 2026 financial guidance. |
| Feb 26 | Earnings date set | Neutral | +4.2% | Announced timing and access details for Q4 and full-year 2025 earnings call. |
| Feb 25 | Investor conferences | Neutral | +10.8% | Outlined participation in multiple healthcare investor conferences in March 2026. |
| Feb 23 | Board appointment | Positive | -0.4% | Appointed an experienced healthcare executive to the Board of Directors. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Corporate and investor-relations updates have often coincided with upward moves, though not consistently; neutral events sometimes saw outsized positive reactions.
This announcement follows a series of corporate and investor-relations milestones for TOI. In March 2026, the company reported Q4 and full-year 2025 results with strong revenue growth and issued 2026 guidance, with shares rising 8.4%. Multiple investor conference participations in February–March 2026 saw a notable 10.85% move. Management and board enhancements in February and April 2026 generally aligned with modest positive price reactions, framing this new conference participation within an active investor-engagement and governance backdrop.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the 25th Annual Needham Healthcare Conference, being held virtually on Wednesday, April 15, 2026, including a fireside chat at 3:45 p.m. ET.
A webcast link of the presentation will be accessible through the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute (www.theoncologyinstitute.com):
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
